JPMorgan Funds - Thematics - Genetic Therapies I Fonds
63,57
EUR
+0,61
EUR
+0,97
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 3,76% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,56% |
| Novartis AG Registered Shares | CH0012005267 | 3,26% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,19% |
| Bio-Techne Corp | US09073M1045 | 3,11% |
| Amgen Inc | US0311621009 | 3,02% |
| Arcellx Inc | US03940C1009 | 2,89% |
| Lonza Group Ltd | CH0013841017 | 2,89% |
| Krystal Biotech Inc | US5011471027 | 2,82% |
| Astellas Pharma Inc | JP3942400007 | 2,81% |
| Sonstige | 68,69% |